These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6981581

  • 1. The use of TNP-conjugated polyacrylamide beads in a C1q binding inhibition test for circulating immune complexes.
    Schmidt R, Walther S, Sodomann CP.
    Immunobiology; 1982; 162(2):153-64. PubMed ID: 6981581
    [Abstract] [Full Text] [Related]

  • 2. Chronic liver disease: the detection and characterization of circulating immune complexes.
    Brown SE, Steward MW, Viola L, Howard CR, Murray-Lyon IM.
    Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
    [Abstract] [Full Text] [Related]

  • 3. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S, McDuffy S, Alarcon-Segovia D, Pope RM.
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [Abstract] [Full Text] [Related]

  • 4. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W, Hiepe F, Courault K, Porstmann B, Apostoloff E.
    Biomed Biochim Acta; 1983 May; 42(7-8):1027-35. PubMed ID: 6360166
    [Abstract] [Full Text] [Related]

  • 5. Cartilage proteoglycan interactions with C1q and the localization of aggregated IgG complexes in cartilage.
    Sparks K, Goetinck P, Ballow M.
    Prog Clin Biol Res; 1982 May; 110 Pt B():113-23. PubMed ID: 6984760
    [No Abstract] [Full Text] [Related]

  • 6. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR, Miltenburg AM, Hiemstra PS, Klar-Mohamad N, Van Es LA, Van Hinsbergh VW.
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [Abstract] [Full Text] [Related]

  • 7. Circulating immune complexes in patients with glomerulonephritis and in renal transplant patients.
    Sølling J.
    Scand J Urol Nephrol Suppl; 1985 May; 97():1-46. PubMed ID: 3915401
    [No Abstract] [Full Text] [Related]

  • 8. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R, van Es LA, Daha MR.
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [Abstract] [Full Text] [Related]

  • 9. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G, Bause I, Kneba M, Kehl A, Nagel GA.
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [Abstract] [Full Text] [Related]

  • 10. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA, Walker LC, Steere AC, Trumble TC, Tung KS, Williams RC, Ruddy S, Malawista SE.
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [Abstract] [Full Text] [Related]

  • 11. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G, Bloemmen FJ, Ceuppens JL, Stevens EA.
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [Abstract] [Full Text] [Related]

  • 12. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
    Sobel A, Gabay Y, Lagrue G.
    Nouv Presse Med; 1976 Jun 05; 5(23):1465-9. PubMed ID: 132639
    [Abstract] [Full Text] [Related]

  • 13. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
    Wener MH, Mannik M.
    Clin Exp Immunol; 1983 Jun 05; 52(3):543-50. PubMed ID: 6603296
    [Abstract] [Full Text] [Related]

  • 14. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
    Araki K, Nagashima H, Tsuji T.
    Clin Exp Immunol; 1982 Mar 05; 47(3):520-6. PubMed ID: 6282506
    [Abstract] [Full Text] [Related]

  • 15. Mutual inhibition of the binding of Clq and protein A to rabbit IgG immune complexes.
    Laky M, Sjöquist J, Moraru I, Gheţie V.
    Mol Immunol; 1985 Nov 05; 22(11):1297-302. PubMed ID: 3878459
    [Abstract] [Full Text] [Related]

  • 16. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E, Sorvillo J, Gigli I.
    J Immunol; 1982 May 05; 128(5):2036-9. PubMed ID: 6801128
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
    Scullion M, Balint G, Whaley K.
    J Clin Lab Immunol; 1979 Apr 05; 2(1):15-22. PubMed ID: 95801
    [Abstract] [Full Text] [Related]

  • 18. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G, Kneba M, Bolz I, Volling P, Wessels J, Nagel GA.
    J Clin Lab Immunol; 1985 Nov 05; 18(3):129-34. PubMed ID: 3878887
    [Abstract] [Full Text] [Related]

  • 19. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME.
    J Lab Clin Med; 1982 May 05; 99(5):678-92. PubMed ID: 6978370
    [Abstract] [Full Text] [Related]

  • 20. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA, Herrmann D, Vogt KH, Jäger L.
    Allerg Immunol (Leipz); 1991 May 05; 37(1):37-45. PubMed ID: 2063729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.